Risk factors for radiation-induced lung toxicity in patients with non-small cell lung cancer who received postoperative radiation therapy

Lung Cancer

Volumn 77, Issue 2, 2012, Pages 326-330

  Zhao, Lujun ^a,b   Ji, Wei ^a   Ou, Guangfei ^a   Lv, Jima ^a   Liang, Jun ^a   Feng, Qinfu ^a   Zhou, Zongmei ^a   Wang, Luhua ^a   Yin, Weibo ^a  

^a CANCER HOSPITAL   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapy; Non small cell lung cancer; Prognosis; Radiation therapy; Radiation induced lung toxicity; Surgery

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CORRELATION ANALYSIS; DOSIMETRY; FEMALE; HUMAN; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POSTOPERATIVE CARE; POSTOPERATIVE RADIATION THERAPY; PRIORITY JOURNAL; RADIATION INDUCED LUNG TOXICITY; RADIATION INJURY; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG INJURY; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RADIATION INJURIES; RISK FACTORS;

EID: 84863778737     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.03.017     Document Type: Article

References (24)

1. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. The Lung Cancer Study Group. N Engl J Med 1986; 315:1377-1381.
2. Trodella L., Granone P., Valente S., Valentini V., Balducci M., Mantini G., et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. Radiother Oncol 2002, 62:11-19.
3. Feng Q.F., Wang M., Wang L.J., Yang Z.Y., Zhang Y.G., Zhang D.W., et al. A study of postoperative radiotherapy in patients with non-small-cell lung cancer: a randomized trial. Int J Radiat Oncol Biol Phys 2000, 47:925-929.
4. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomized controlled trials. PORT Meta-analysis Trialists Group. Lancet 1998; 352:257-263.
5. Lally B.E., Detterbeck F.C., Geiger A.M., Thomas C.R., Machtay M., Miller A.A., et al. The risk of death from heart disease in patients with non-small cell lung cancer who receive postoperative radiotherapy: analysis of the surveillance, epidemiology, and end results database. Cancer 2007, 110:911-917.
6. Lally B.E., Zelterman D., Colasanto J.M., Haffty B.G., Detterbeck F.C., Wilson L.D. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 2006, 24:2998-3006.
7. Barriger R.B., Fakiris A.J., Hanna N., Yu M., Mantravadi P., McGarry R.C. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel. Int J Radiat Oncol Biol Phys 2010, 78:1381-1386.
8. Zhao L., Sheldon K., Chen M., Yin M.S., Hayman J.A., Kalemkerian G.P., et al. The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer. Lung Cancer 2008, 59:232-239.
9. Kong F.M., Hayman J.A., Griffith K.A., Kalemkerian G.P., Arenberg D., Lyons S., et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 2006, 65:1075-1086.
10. Wang S., Liao Z., Wei X., Liu H.H., Tucker S.L., Hu C.S., et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 2006, 66:1399-1407.
11. Saynak M., Higginson D.S., Morris D.E., Marks L.B. Current status of postoperative radiation for non-small-cell lung cancer. Semin Radiat Oncol 2010, 20:192-200.
12. Sawyer T.E., Bonner J.A., Gould P.M., Foote R.L., Deschamps C., Trastek V.F., et al. Effectiveness of postoperative irradiation in stage IIIA non-small cell lung cancer according to regression tree analyses of recurrence risks. Ann Thorac Surg 1997, 64:1402-1407. [discussion 1407-1408].
13. Bradley J.D., Paulus R., Graham M.V., Ettinger D.S., Johnstone D.W., Pilepich M.V., et al. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group-RTOG 9705. J Clin Oncol 2005, 23:3480-3487.
14. Douillard J.Y., Rosell R., De Lena M., Riggi M., Hurteloup P., Mahe M.A. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Int J Radiat Oncol Biol Phys 2008, 72:695-701.
15. Miles E.F., Kelsey C.R., Kirkpatrick J.P., Marks L.B. Estimating the magnitude and field-size dependence of radiotherapy-induced mortality and tumor control after postoperative radiotherapy for non-small-cell lung cancer: calculations from clinical trials. Int J Radiat Oncol Biol Phys 2007, 68:1047-1052.
16. Machtay M., Lee J.H., Shrager J.B., Kaiser L.R., Glatstein E. Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma. J Clin Oncol 2001, 19:3912-3917.
17. Dautzenberg B., Arriagada R., Chammard A.B., Jarema A., Mezzetti M., Mattson K., et al. A controlled study of postoperative radiotherapy for patients with completely resected non-small cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques. Cancer 1999, 86:265-273.
18. Ohe Y., Yamamoto S., Suzuki K., Hojo F., Kakinuma R., Matsumoto T., et al. Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer. Eur J Cancer 2001, 37:54-63.
19. Rancati T., Ceresoli G.L., Gagliardi G., Schipani S., Cattaneo G.M. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol 2003, 67:275-283.
20. Das S.K., Zhou S., Zhang J., Yin F.F., Dewhirst M.W., Marks L.B. Predicting lung radiotherapy-induced pneumonitis using a model combining parametric Lyman probit with nonparametric decision trees. Int J Radiat Oncol Biol Phys 2007, 68:1212-1221.
21. Huang E.X., Hope A.J., Lindsay P.E., Trovo M., El Naqa I., Deasy J.O., et al. Heart irradiation as a risk factor for radiation pneumonitis. Acta Oncol 2011, 50:51-60.
22. Das A.K., Sato M., Story M.D., Peyton M., Graves R., Redpath S., et al. Non-small-cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiation. Cancer Res 2006, 66:9601-9608.
23. Parashar B., Edwards A., Mehta R., Pasmantier M., Wernicke A.G., Sabbas A., et al. Chemotherapy significantly increases the risk of radiation pneumonitis in radiation therapy of advanced lung cancer. Am J Clin Oncol 2011, 34:160-164.
24. Arriagada R., Auperin A., Burdett S., Higgins J.P., Johnson D.H., Le Chevalier T., et al. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet 2010, 375:1267-1277.